JPRN-jRCT1080220847未知4 期
A postmarketing clinical study on ART-123 in patients with disseminated intravascular coagulation (DIC) directly caused by solid tumor
ASAHI KASEI PHARMA CORPORATIO0 个研究点目标入组 100 人开始时间: 2009年9月7日最近更新:
适应症
试验速览
- 阶段
- 4 期
- 发起方
- 入组人数
- 100
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 20age old 至 ot applicable（—）
- 性别
- All
入选标准
- •Patients given a diagnosis of DIC on the basis of criteria established by the DIC research group of the Ministry of Health and Welfare of Japan
- •-Patients with DIC directly caused by solid tumor
- •-20 years old and older
排除标准
- •-Patients showing intracranial, pulmonary, gastrointestinal hemorrhage
- •-Patients with a history of cerebrovascular disorders within the past 52 week
- •-Patients with a history of hypersensitivity to the ingredients of ART-123 preparations
- •-Pregnant women, nursing mothers or possibly pregnant women
研究者
相似试验
已完成
3 期
Phase III Clinical Study on ART-123 in patients with disseminated intravascular coagulation (DIC) directly caused by malignant hematopoietic tumors or infections (Multicenter double-blind randomized parallel group comparative study with heparin sodium as control drug)Disseminated intravascular coagulation (DIC) directly caused by malignant hematopoietic tumors or infectionsJPRN-C000000327Asahi Kasei Pharma Corporation220
未知
3 期
Phase III Clinical Study on ART-123 in patients with disseminated intravascular coagulation (DIC) directly caused by malignant hematopoietic tumors or infectionsDisseminated intravascular coagulation (DIC)JPRN-jRCT2080220059ASAHIKASEI PHARMA CORPORATIO
已完成
3 期
Phase III clinical study of ART-123 for the treatment of acute exacerbation of idiopathic pulmonary fibrosisAcute exacerbation of idiopathic pulmonary fibrosis (AE-IPF)JPRN-jRCT2080223271ASAHI KASEI PHARMA CORPORATIO74
尚未招募
Unknown
Clinical study of ART-A & -SR for patient with recurrent IVF failure, repeated pregnancy losses, and patient who has chromosomal structural rearrangement.JPRN-UMIN000053739Tohoku university10
已完成
不适用
A post market clinical follow-up study with the artificial hip joint CBH Stem, with initial RSA analysiship arthroplastyhip replacement10023213NL-OMON47657Xpert Orthopedie150